Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles N Bernstein

Showing results (11-20 of 649) with videos related to

Pageof 65
Sort By:
Gut|August 23, 2008
Surveillance programmes for colorectal cancer in inflammatory bowel disease: have we got it right?Charles N Bernstein
Digestive Diseases (Basel, Switzerland)|October 8, 2010
New insights into IBD epidemiology: Are there any lessons for treatment?Charles N Bernstein
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 5, 2004
Complementary and alternative medicine use by patients with inflammatory bowel disease: are Canadian physicians failing with conventional therapy, or not?Charles N Bernstein
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Addressing Mental Health in Persons with IBDCharles N Bernstein
The American Journal of Gastroenterology|August 28, 2004
A BALANCING VIEW: Dysplasia surveillance in ulcerative colitis--sorting the pro from the conCharles N Bernstein
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 11, 2005
Limiting fracture risk in Crohn's disease: is there anything better than calcium and vitamin D?Charles N Bernstein
Current Opinion in Gastroenterology|October 13, 2006
Osteoporosis and other complications of inflammatory bowel diseaseCharles N Bernstein
Gastroenterology & Hepatology|August 13, 2013
Antibiotic use and the risk of Crohn's diseaseCharles N Bernstein
Inflammatory Bowel Diseases|April 9, 2002
Section Editor's Commentary. Infliximab as First-Line Therapy for Crohn's DiseaseCharles N. Bernstein
Current Opinion in Gastroenterology|April 27, 2016
Does everyone with inflammatory bowel disease need to be treated with combination therapy?Charles N Bernstein
Pageof 65

Showing results (11-20 of 649) with videos related to

Sort By:
Pageof 65
Gut|August 23, 2008
Surveillance programmes for colorectal cancer in inflammatory bowel disease: have we got it right?Charles N Bernstein
Digestive Diseases (Basel, Switzerland)|October 8, 2010
New insights into IBD epidemiology: Are there any lessons for treatment?Charles N Bernstein
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 5, 2004
Complementary and alternative medicine use by patients with inflammatory bowel disease: are Canadian physicians failing with conventional therapy, or not?Charles N Bernstein
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Addressing Mental Health in Persons with IBDCharles N Bernstein
The American Journal of Gastroenterology|August 28, 2004
A BALANCING VIEW: Dysplasia surveillance in ulcerative colitis--sorting the pro from the conCharles N Bernstein
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 11, 2005
Limiting fracture risk in Crohn's disease: is there anything better than calcium and vitamin D?Charles N Bernstein
Current Opinion in Gastroenterology|October 13, 2006
Osteoporosis and other complications of inflammatory bowel diseaseCharles N Bernstein
Gastroenterology & Hepatology|August 13, 2013
Antibiotic use and the risk of Crohn's diseaseCharles N Bernstein
Inflammatory Bowel Diseases|April 9, 2002
Section Editor's Commentary. Infliximab as First-Line Therapy for Crohn's DiseaseCharles N. Bernstein
Current Opinion in Gastroenterology|April 27, 2016
Does everyone with inflammatory bowel disease need to be treated with combination therapy?Charles N Bernstein
Pageof 65